| RS2540425440 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome, Proportionate short stature |
| RS2540425549 |
PTPN11
|
Health Risk |
Likely pathogenic |
PTPN11-related disorder, PTPN11-related disorder |
| RS2540425577 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2540426135 |
IRAK4
|
Health Risk |
Pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS2540426895 |
C5
|
Health Risk |
Likely pathogenic |
— |
| RS2540427371 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2540430178 |
C5
|
Health Risk |
Pathogenic |
— |
| RS2540431049 |
EPS8
|
Health Risk |
Pathogenic |
— |
| RS2540431340 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2540436107 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540436238 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540436280 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540436320 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540436653 |
IRAK4
|
Health Risk |
Pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS2540437045 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2540437588 |
NOTCH1
|
Health Risk |
Pathogenic |
NOTCH1-related disorder, NOTCH1-related disorder |
| RS2540437866 |
POC1B
|
Health Risk |
Likely pathogenic |
— |
| RS2540440269 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2540444114 |
NOTCH1
|
Health Risk |
Pathogenic |
NOTCH1-related disorder, NOTCH1-related disorder |
| RS2540444867 |
POC1B
|
Health Risk |
Likely pathogenic |
— |
| RS2540445590 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 1, Juvenile myelomonocytic leukemia |
| RS2540446470 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2540452202 |
NOTCH1
|
Health Risk |
Pathogenic |
— |
| RS2540452270 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2540452961 |
NOTCH1
|
Health Risk |
Pathogenic |
Aortic valve disease 1, Adams-Oliver syndrome 5 |
| RS2540455720 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2540455872 |
NOTCH1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2540456451 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2540457138 |
PTPN11
|
Health Risk |
Likely pathogenic |
Noonan syndrome 1, Noonan syndrome 1 |
| RS2540457229 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS2540457334 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540457665 |
NOTCH1
|
Health Risk |
Likely pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS2540457891 |
TBX5
|
Health Risk |
Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540458625 |
C5
|
Health Risk |
Likely pathogenic |
— |
| RS2540458943 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2540459597 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, NOTCH1-related disorder |
| RS2540461112 |
C5
|
Health Risk |
Pathogenic |
— |
| RS2540461335 |
CEP164
|
Health Risk |
Likely pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2540462269 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2540464494 |
C5
|
Health Risk |
Pathogenic |
— |
| RS2540465831 |
PTPN11
|
Health Risk |
Likely pathogenic |
Metachondromatosis, Metachondromatosis |
| RS2540466994 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540467152 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540467182 |
TBX5
|
Health Risk |
Likely pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540470663 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS2540470879 |
TRAPPC9
|
Health Risk |
Pathogenic |
— |
| RS2540471325 |
TBX5
|
Health Risk |
Likely pathogenic |
— |
| RS2540471405 |
TBX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540471436 |
TBX5
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540471519 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS2540471641 |
TBX5
|
Health Risk |
Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540472643 |
TBX5
|
Health Risk |
Likely pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540472661 |
TBX5
|
Health Risk |
Pathogenic |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540475270 |
TBX5
|
Health Risk |
Likely pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540475443 |
TBX5
|
Health Risk |
Pathogenic |
— |
| RS2540475446 |
TBX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Holt-Oram syndrome, Holt-Oram syndrome |
| RS2540477662 |
TBX5
|
Health Risk |
Pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2540481422 |
IRAK4
|
Health Risk |
Pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS2540481495 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2540488916 |
IRAK4
|
Health Risk |
Pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS2540492451 |
NOTCH1
|
Health Risk |
Likely pathogenic |
— |
| RS2540492992 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2540493207 |
KIF5A
|
Health Risk |
Likely pathogenic |
Peripheral neuropathy, Peripheral neuropathy |
| RS2540493214 |
KIF5A
|
Health Risk |
Pathogenic |
— |
| RS2540494891 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540494895 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2540496937 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540499310 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2540499352 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2540499468 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS2540499492 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS2540501760 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540503039 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540508034 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540508044 |
KIF5A
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540509221 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540511791 |
KIF5A
|
Health Risk |
Likely pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS2540515401 |
KIF5A
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540515721 |
KIF5A
|
Health Risk |
Likely pathogenic |
Myoclonus, intractable |
| RS2540516288 |
KIF5A
|
Health Risk |
Likely pathogenic |
KIF5A-related disorder, KIF5A-related disorder |
| RS2540517278 |
KIF5A
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2540520556 |
ACBD5
|
Health Risk |
Pathogenic |
— |
| RS2540534282 |
GYS2
|
Health Risk |
Pathogenic |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |
| RS2540545009 |
TRAPPC9
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 13 |
| RS2540546209 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 13 |
| RS2540548302 |
FGD4
|
Health Risk |
Pathogenic |
— |
| RS2540549307 |
DIP2C
|
Health Risk |
Pathogenic |
— |
| RS2540549360 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS2540556962 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540557166 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540557182 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540560824 |
POC1B
|
Health Risk |
Pathogenic |
— |
| RS2540573705 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540574261 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540574296 |
GLE1
|
Health Risk |
Pathogenic |
— |
| RS2540574448 |
SUOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540575551 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540575913 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |
| RS2540575955 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, SUOX-related disorder |
| RS2540575967 |
SUOX
|
Health Risk |
Pathogenic |
Sulfite oxidase deficiency, Sulfite oxidase deficiency |